223 related articles for article (PubMed ID: 21847014)
1. Insoluble cellular prion protein and its association with prion and Alzheimer diseases.
Zou WQ; Zhou X; Yuan J; Xiao X
Prion; 2011; 5(3):172-8. PubMed ID: 21847014
[TBL] [Abstract][Full Text] [Related]
2. Isolation of soluble and insoluble PrP oligomers in the normal human brain.
Xiao X; Yuan J; Zou WQ
J Vis Exp; 2012 Oct; (68):. PubMed ID: 23070047
[TBL] [Abstract][Full Text] [Related]
3. The P's and Q's of cellular PrP-Aβ interactions.
Westaway D; Jhamandas JH
Prion; 2012; 6(4):359-63. PubMed ID: 22874673
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain.
Zou WQ; Xiao X; Yuan J; Puoti G; Fujioka H; Wang X; Richardson S; Zhou X; Zou R; Li S; Zhu X; McGeer PL; McGeehan J; Kneale G; Rincon-Limas DE; Fernandez-Funez P; Lee HG; Smith MA; Petersen RB; Guo JP
J Biol Chem; 2011 Apr; 286(17):15095-105. PubMed ID: 21393248
[TBL] [Abstract][Full Text] [Related]
5. Prion protein functions and dysfunction in prion diseases.
Sakudo A; Ikuta K
Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.
Ulbrich S; Janning P; Seidel R; Matschke J; Gonsberg A; Jung S; Glatzel M; Engelhard M; Winklhofer KF; Tatzelt J
PLoS One; 2018; 13(5):e0197659. PubMed ID: 29791485
[TBL] [Abstract][Full Text] [Related]
7. The cellular prion protein and its role in Alzheimer disease.
Velayos JL; Irujo A; Cuadrado-Tejedor M; Paternain B; Moleres FJ; Ferrer V
Prion; 2009; 3(2):110-7. PubMed ID: 19556894
[TBL] [Abstract][Full Text] [Related]
8. Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.
Nygaard HB; Strittmatter SM
Arch Neurol; 2009 Nov; 66(11):1325-8. PubMed ID: 19901162
[TBL] [Abstract][Full Text] [Related]
9. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
Shoup D; Priola SA
Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
[TBL] [Abstract][Full Text] [Related]
10. Prion protein and Alzheimer disease.
Kellett KA; Hooper NM
Prion; 2009; 3(4):190-4. PubMed ID: 19887909
[TBL] [Abstract][Full Text] [Related]
11. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy.
Zanusso G; Vattemi G; Ferrari S; Tabaton M; Pecini E; Cavallaro T; Tomelleri G; Filosto M; Tonin P; Nardelli E; Rizzuto N; Monaco S
Brain Pathol; 2001 Apr; 11(2):182-9. PubMed ID: 11303793
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.
Um JW; Strittmatter SM
Prion; 2013; 7(1):37-41. PubMed ID: 22987042
[TBL] [Abstract][Full Text] [Related]
14. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
15. Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates.
Béland M; Bédard M; Tremblay G; Lavigne P; Roucou X
Neurobiol Aging; 2014 Jul; 35(7):1537-48. PubMed ID: 24602510
[TBL] [Abstract][Full Text] [Related]
16. Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.
Béland M; Roucou X
Prion; 2014; 8(1):106-10. PubMed ID: 24335160
[TBL] [Abstract][Full Text] [Related]
17. A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.
Imberdis T; Ayrolles-Torro A; Duarte Rodrigues A; Torrent J; Alvarez-Martinez MT; Kovacs GG; Verdier JM; Robitzer M; Perrier V
Mol Neurodegener; 2016 Jan; 11():11. PubMed ID: 26809712
[TBL] [Abstract][Full Text] [Related]
18. Microbiome Influence in the Pathogenesis of Prion and Alzheimer's Diseases.
D'Argenio V; Sarnataro D
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547531
[TBL] [Abstract][Full Text] [Related]
19. Neurometals in the Pathogenesis of Prion Diseases.
Kawahara M; Kato-Negishi M; Tanaka KI
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
[TBL] [Abstract][Full Text] [Related]
20. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
Zou WQ; Cashman NR
J Biol Chem; 2002 Nov; 277(46):43942-7. PubMed ID: 12161431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
